[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365358-105":59,"doc-detail-365358-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","in-vivo-antitumor-activity-of-allicin-in-a-pediatric-neuroblastoma-patient-derived-xenograft-pdx-mouse-model","In Vivo Antitumor Activity of Allicin in a Pediatric Neuroblastoma Patient-derived Xenograft (PDX) Mouse Model","","Background/Aim: Allicin, a garlic-derived small-molecule natural product, inhibits ornithine decarboxylase (ODC) in vitro and induces apoptotic death in pediatric neuroblastoma (NB) cell cultures, yet its in vivo anticancer potency remains insufficiently explored. Materials and Methods: Cell proliferation assays, immunoblotting, and light microscopy assessed NB cultures and control fibroblasts, and a MYCN-amplified NB patient-derived xenograft (PDX) mouse model. Results: Allicin dose-dependently suppressed NB proliferation with minimal effects on fibroblasts; two intra-tumoral injections reduced tumor burden and increased p27Kip1, indicating G1/S arrest. Conclusion: The data support further preclinical development for intra-tumor-injectable cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/in-vivo-antitumor-activity-of-allicin-in-a-pediatric-neuroblastoma-patient-derived-xenograft-pdx-mouse-model/365358/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/in-vivo-antitumor-activity-of-allicin-in-a-pediatric-neuroblastoma-patient-derived-xenograft-pdx-mouse-model/365358.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about allicin?","Question",{"text":112,"@type":113},"It evaluates whether allicin has sufficient anticancer potency in vivo, beyond prior in vitro findings in pediatric neuroblastoma models.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was allicin tested in this research?",{"text":117,"@type":113},"The study used cell proliferation assays, immunoblotting, and light microscopy, including NB cultures and control fibroblasts, as well as a MYCN-amplified NB patient-derived xenograft (PDX) mouse model.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biological effects did allicin produce in vivo and in cells?",{"text":121,"@type":113},"Allicin strongly inhibited NB tumor cell proliferation dose-dependently, reduced tumor burden after intra-tumoral injections, and increased the p27Kip1 protein level, consistent with G1/S cell cycle arrest.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365358,1791402326,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","doi: 10.21873/invivo.13932  \nIn Vivo Antitumor Activity of Allicin ina Pediatric Neuroblastoma Patient‐derived Xenograft (PDX) Mouse Model  \nCHAD R. SCHULTZ1, MARTIN C. H. GRUHLKE2, ALAN J. SLUSARENKO2,3 and ANDRÉ S. BACHMANN1  \n1 Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, U.S.A.;  \n2Society for Natural Product and Drug Research (GENAWIF), Aachen, Germany; 3 Department of Plant Physiology, RWTH Aachen University, Aachen, Germany  \nAbstract  \nBackground/Aim: Allicin is a small‑molecule natural product found in garlic (Allium sativum). We previously showed that allicin inhibits ornithine decarboxylase (ODC) in vitro and induces apoptotic cell death in pediatric neuroblastoma (NB) cancer cell cultures. However, its potency as an anticancer agent in vivo has not been sufficiently explored.  \nMaterials and Methods: In this study, we used cell proliferation assays, immunoblotting techniques, and light microscopy to study NB tumor cell cultures and human primary neonatal skin fibroblast control cells as well as a MYCN‑amplified NB patient‑derived xenograft (PDX) mouse tumor model to study the efficacy of allicin in vivo. Results: Allicin strongly inhibits NB tumor cell proliferation in a dose‑dependent manner while non‑cancerous human primary neonatal skin fibroblast control cells were largely unaffected. Importantly, two intra‑tumoral injections of allicin over a two‑week trial period significantly reduced the NB tumor burden in mice compared to controls (N=4‑ 9 mice/group) . Excised tumor tissues revealed that allicin treatment increased the cyclin‑dependent kinase inhibitor p27Kip1 protein levels, suggesting that in vivo, allicin increases p27Kip1‑mediated G1/S cell cycle arrest.  \nConclusion: Our findings warrant further preclinical development of allicin as a potential anticancer agent, especially for those types of cancers that are treatable by intra‑tumoral injections, including neuroblastoma, glioblastoma, and medulloblastoma.  \nKeywords: Allicin, childhood cancer, in vivo antitumor activity, intra‑tumoral injection, natural products, neuroblastoma, patient‑derived xenograft (PDX) .  \n✉  \nAndré S. Bachmann, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, 400 Monroe Ave, NW, Grand Rapids, MI 49503, U.S.A. Tel: +1 6162342841, e‑[mail: bachma26@msu.edu](mail: bachma26@msu.edu)  \nReceived January 21, 2025 | Revised February 14, 2025 | Accepted March 4, 2025  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2025 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nIntroduction  \nWhen tissues of garlic (Allium sativum) are damaged they release the natural product allicin, the pungent‑smelling volatile organic sulfur compound (VOSC), that is the typical odor of fresh garlic (1, 2) (Figure 1A and B). Allicin reacts reversibly with cellular thiols (R‑SH) by making adisulfide bridge with an allyl group attached, i.e., R‑SH becomes R‑S‑S‑CH2‑CH=CH2. The low molecular weight thiol glutathione and proteins containing cysteine are typical cellular targets for allicin and the disulfide bridge inthethioallylated products can be reduced back tothiols, thus making allicin effects reversible at sublethal levels. When cellular proteins are affected in this way their activity can become altered, and this makes allicin a dose‑ dependent biocide (1) . The S‑thioallylation reaction is central to allicin’s biological reactivity and, significantly, has also been shown tobe performed by other compounds like allyl polysulfanes, found in aged garlic products and garlic oils where no allicin is present (3).  \nMYCN gene amplification is often associated with high‑ risk neuroblastoma (NB), a fatal pediatric cancer, where r","cbCaiheHNicJ2dla","https://ap.wps.com/l/cbCaiheHNicJ2dla","pdf",1294989,"English","# Introduction\n# Materials and Methods\n## Chemicals, reagents, and antibodies\n## Cell culture\n# Abstract (Background/Aim; Materials and Methods; Results; Conclusion)","[{\"question\":\"What question does the study address about allicin?\",\"answer\":\"It evaluates whether allicin has sufficient anticancer potency in vivo, beyond prior in vitro findings in pediatric neuroblastoma models.\"},{\"question\":\"How was allicin tested in this research?\",\"answer\":\"The study used cell proliferation assays, immunoblotting, and light microscopy, including NB cultures and control fibroblasts, as well as a MYCN-amplified NB patient-derived xenograft (PDX) mouse model.\"},{\"question\":\"What key biological effects did allicin produce in vivo and in cells?\",\"answer\":\"Allicin strongly inhibited NB tumor cell proliferation dose-dependently, reduced tumor burden after intra-tumoral injections, and increased the p27Kip1 protein level, consistent with G1/S cell cycle arrest.\"}]","In Vivo Antitumor Activity of Allicin in a Pediatric Neuroblastoma Patient-derived Xenograft (PDX) Mouse Model | PDF",1790160715,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51f27881ed8668c1796ce6295df472a8.webp",983,1301,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fc661766bb5862fcd185d5b6d8d8561.webp",982,1299,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cca90fcb3cb4c927682a43ff1134a054.webp",981,1298,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/980bd4b90026d9fa5175fb77414bd174.webp",980,1297]